Income from operations throughout Q4FY26 rose 17% year-on-year to Rs 701 crore from Rs 599 crore reported within the corresponding quarter of the earlier monetary yr. On a sequential foundation, revenue after tax elevated 40% from Rs 42 crore posted in Q3FY26, whilst income declined almost 6% from Rs 744 crore recorded within the October-December quarter.
For the total monetary yr FY26, the corporate posted income of Rs 2,711 crore in contrast with Rs 2,274 crore in FY25, reflecting a development of 19%. The corporate additionally swung to a revenue of Rs 113 crore throughout the yr, towards a lack of Rs 145 crore within the earlier monetary yr.
Pine Labs share value: Purchase, promote, maintain?
Morgan Stanley has maintained its “Equal-weight” score on Pine Labs with a goal value of Rs 245, an upside of 67%. The brokerage famous that This fall income development of 17% year-on-year got here in round 3% beneath consensus estimates, whereas adjusted EBITDA rose 73% year-on-year however was marginally beneath expectations.
Administration has guided for medium-term income development of 21-23.5%. Morgan Stanley highlighted that the issuing and buying enterprise continued to publish sturdy development of 24% year-on-year, whereas move, affordability and transaction processing GTV elevated 44% year-on-year.
The brokerage additionally pointed to a pointy enchancment in working leverage and money move conversion throughout FY26. Nonetheless, it famous that the corporate’s worldwide enterprise was affected by geopolitical tensions within the Center East. Web money stood at Rs 24.5 billion on the finish of March 2026.
Pine Labs shares are down 24% within the final 1 month and about 36% because the starting of the yr. The fintech firm made a robust debut on the BSE on November 14,, itemizing at Rs 242 per share, a 9.5% premium over its IPO value of Rs 221.
(Disclaimer: Suggestions, recommendations, views and opinions given by the specialists are their very own. These don’t symbolize the views of The Financial Occasions)
